Am J Transplant, Volume 21, Suppl 3 Archives - Page 139 of 139 - ATC Abstracts

2021 American Transplant Congress
Donor Derived Cell-free-dna (dd-cfdna) as a Surrogate Marker for Kidney Biopsy- Indiana University Transplant Nephrology Experience
S. Valavoor¹, A. Sharfuddin², G. William³, M. Yaqub¹, D. Mishler¹, O. Adebiyi²
¹Nephrology, Indiana University, Indianapolis, IN, ²Transplant Nephrology, Indiana University, Indianapolis, IN, ³Transplant Surgery, Indiana University, Indianapolis, IN
*Purpose: Patient monitoring after kidney transplantation (KT) for early detection of allograft rejection remains key in preventing allograft loss. Donor-derived cell-free DNA (dd-cfDNA), a noninvasive…
2021 American Transplant Congress
A Psychosocial Clinician Rating Scale is Used Differently Across Solid Organ Teams within a Single Transplant Center
S. Entenman¹, T. Chaffee², M. Pienta³, B. Young³, E. Clifton¹, J. Mellinger⁴, L. McElroy⁵, G. Winder¹
¹Psychiatry, University of Michigan, Ann Arbor, MI, ²Psychiatry, University of Missouri-Kansas City, Kansas City, MO, ³Surgery, University of Michigan, Ann Arbor, MI, ⁴Internal Medicine, University of Michigan, Ann Arbor, MI, ⁵Surgery, Duke University, Durham, NC
*Purpose: Transplant psychosocial clinician rating scales like the Stanford Integrated Psychosocial Assessment for Transplant (SIPAT) are widely used tools to standardize subjective patient data, stratify…
2021 American Transplant Congress
Right Ventricular Dysfunction After Heart Transplantation: When to Worry?
S. Kim, J. Patel, M. Kittleson, T. Singer-Englar, N. Patel, R. Skorka, D. Chang, E. Kransdorf, M. Hamilton, B. Azarbal, L. Czer, D. Ramzy, J. A. Kobashigawa
Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
*Purpose: Right ventricular (RV) dysfunction after heart transplantation (HTx) is not uncommon. The cause of RV dysfunction may be due to inadequate preservation, high pulmonary…
2021 American Transplant Congress
Comparison of Outcomes in Sot Recipients During Two Eras of Covid-19 Therapeutics
T. Chiang, A. Sait, A. Massie, K. Marr, D. Brennan, W. Cochran, P. Shah, T. Jain, S. Mehta Steinke, N. Desai, N. Permpalung, S. Shoham, C. Merlo, C. Durand, W. Werbel, M. Dioverti, D. Ostrander, A. Gurakar, M. Y. Kim, J. Garonzik-Wang, D. Segev, R. Avery
Johns Hopkins University, Baltimore, MD
*Purpose: COVID-19 therapies have evolved over time, but little is known regarding outcomes in SOT recipients treated with newer therapeutic agents such as remdesivir, dexamethasone,…
2021 American Transplant Congress
Clinical Course and Outcomes in Solid Organ Transplant Recipients with Covid-19
R. C. Jackson¹, S. Challa², A. Halim¹, N. Kelly³, D. Maluf⁴, K. Shetty³, Z. Lominadze³
¹Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, ²Internal Medicine, University of Maryland Medical Center Midtown, Baltimore, MD, ³Program in Transplantation, Department of Medicine, University of Maryland Medical System, Baltimore, MD, ⁴Program in Transplantation, University of Maryland Medical System, Baltimore, MD
*Purpose: We characterized the outcomes of COVID-19 in our population of solid organ transplant recipients (SOTRs). Since these individuals are immunocompromised, with multiple comorbidities, we…
2021 American Transplant Congress
Covid-19 in Hiv-infected Solid Organ Transplant Recipients: A Case Series
M. Ramanathan, A. Fernandez, Y. Natori, J. Simkins, J. Camargo, M. Morris, N. Rivera, M. Loebe, G. Ciancio, L. Abbo, A. Mattiazzi, G. Guerra, S. Anjan
University of Miami, Miami, FL
*Purpose: Coronavirus disease 2019 (COVID-19) is associated with increased mortality and morbidity in immunosuppressed patients. Data on management and outcomes in HIV-infected solid organ transplant…
2021 American Transplant Congress
Variation of Mortality from SARS-CoV-2 Infection in Kidney Transplant Recipients Over the Course of the Pandemic
Y. Al Azzi, C. Pynadath, P. Loarte, O. Alani, L. Liriano-Ward, M. Ajaimy, R. Bartash, J. Graham, M. Le, H. Yaffe, S. Greenstein, J. Rocca, M. Kinkhabwala, E. Akalin
Montefiore Medical Center, New York, NY
*Purpose: We aimed to investigate the mortality from SARS-CoV-2 in kidney transplant recipients in the Bronx, New York, one of the epicenters of the pandemic…
2021 American Transplant Congress
Infectious Complications and Malignancy After Kidney Transplantation in the Elderly Population
L. Liriano-Ward, M. Parides, Y. Al Azzi, C. Pynadath, M. Ajaimy, P. Loarte, J. Graham, S. Greenstein, M. Le, H. Yaffe, M. Kinkhabwala, J. Rocca, E. Akalin
Montefiore Medical Center, New York, NY
*Purpose: All patients, regardless of age, may benefit from renal transplantation due to improved quality of life and decreased mortality. However, elderly patients are at…
2021 American Transplant Congress
Belatacept Pharmacokinetics in Patients with and without Infection
A. Bickenbach¹, M. McGowan¹, B. Miyagawa², T. Mizuno², A. Shields³, A. Christianson¹, P. West-Thielke⁴, J. Leone⁵, E. Woodle¹, D. Kaufman⁶, A. Wiseman⁷, A. Vinks², R. Alloway¹
¹U Cincinnati, Cincinnati, OH, ²Cincinnati Children's Med Center, Cincinnati, OH, ³Christ Hospital, Cincinnati, OH, ⁴UIC, Chicago, IL, ⁵Tampa Gen, Tampa, FL, ⁶U Wisconsin, Madison, WI, ⁷Centura Transplant, Denver, CO
*Purpose: Two belatacept(BELA) fixed mg/kg dosing regimens, less intense(LI) and more intense(MI) were compared. The LI regimen was approved due to the higher risk profile…